ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 19:56
ACADIA Pharmaceuticals Total Assets (Quarterly) : 1.743B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.743B |
| March 31, 2026 | 1.605B |
| December 31, 2025 | 1.564B |
| September 30, 2025 | 1.331B |
| June 30, 2025 | 1.226B |
| March 31, 2025 | 1.132B |
| December 31, 2024 | 1.188B |
| September 30, 2024 | 976.87M |
| June 30, 2024 | 914.10M |
| March 31, 2024 | 855.10M |
| December 31, 2023 | 748.96M |
| September 30, 2023 | 632.54M |
| June 30, 2023 | 642.77M |
| March 31, 2023 | 655.30M |
| December 31, 2022 | 587.81M |
| September 30, 2022 | 602.49M |
| June 30, 2022 | 612.77M |
| March 31, 2022 | 624.25M |
| December 31, 2021 | 700.12M |
| September 30, 2021 | 717.67M |
| June 30, 2021 | 724.43M |
| March 31, 2021 | 755.17M |
| December 31, 2020 | 782.62M |
| September 30, 2020 | 795.66M |
| June 30, 2020 | 759.65M |
| Date | Value |
|---|---|
| March 31, 2020 | 747.45M |
| December 31, 2019 | 783.18M |
| September 30, 2019 | 765.59M |
| June 30, 2019 | 460.88M |
| March 31, 2019 | 501.10M |
| December 31, 2018 | 540.20M |
| September 30, 2018 | 266.46M |
| June 30, 2018 | 314.96M |
| March 31, 2018 | 351.04M |
| December 31, 2017 | 384.51M |
| September 30, 2017 | 413.71M |
| June 30, 2017 | 456.32M |
| March 31, 2017 | 503.01M |
| December 31, 2016 | 561.15M |
| September 30, 2016 | 617.38M |
| June 30, 2016 | 438.03M |
| March 31, 2016 | 466.59M |
| December 31, 2015 | 221.90M |
| September 30, 2015 | 245.32M |
| June 30, 2015 | 275.54M |
| March 31, 2015 | 301.96M |
| December 31, 2014 | 325.46M |
| September 30, 2014 | 341.76M |
| June 30, 2014 | 359.46M |
| March 31, 2014 | 373.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Incyte Corp. | 7.873B |
| Agios Pharmaceuticals, Inc. | 1.108B |
| Biogen, Inc. | 32.09B |
| Insmed, Inc. | 2.103B |
| Vertex Pharmaceuticals, Inc. | 27.42B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 436.29M |
| Shareholders Equity (Quarterly) | 1.307B |
| Debt to Equity Ratio | 0.0565 |
| Current Ratio | 3.388 |
| Net Debt Paydown Yield | -0.08% |